Presenting how data transformation is measured as part of the SAFE Data Standard, which data variables influence the rating and, how the appropriate level of data transformation is calculated.
Stephen Bamford
Advertisement
Head of Clinical Data Standards & Transparency, The Janssen Pharmaceutical Companies of Johnson & Johnson
Articles by Stephen Bamford
Advertisement
Latest Updated Articles
- Sharing Anonymized and Functionally Effective (SAFE) Data Standard for Safely Sharing Rich Clinical Trial Data
Published: April 8th 2022 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
2
Reducing Site Burden Through Better Technology Integration in Clinical Trials
3
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
